Yes. Cephalexin can be absorbed effectively with or without food. If you experience stomach upset, taking the tablet with a small amount of food may improve tolerability.
Clinical improvement is typically observed within 48 to 72 hours of starting therapy, although the drug begins to inhibit bacterial growth within a few hours of the first dose.
Some studies suggest that cephalexin may reduce the effectiveness of hormonal contraceptives. Using a backup non-hormonal method (e.g., condoms) during treatment and for a few days after completing the antibiotic is advisable.
A mild rash may be a common side effect, but any skin reaction accompanied by swelling, hives, or difficulty breathing requires immediate medical attention, as it could indicate an allergic response.
Alcohol does not have a direct pharmacological interaction with cephalexin, but excessive alcohol consumption can worsen gastrointestinal side effects such as nausea and diarrhoea.
Cephalexin is sometimes prescribed as an alternative for patients allergic to penicillins undergoing certain dental procedures. This use is guided by clinical guidelines and should be decided by your dentist or physician.
Keep the tablets in their original container, protected from heat, humidity, and light. If you will be away from the UK for an extended period, ensure you have a valid prescription and comply with the destination country's import regulations.
Serious signs include swelling of the face, lips, or throat; wheezing; difficulty breathing; and a rapid or irregular heartbeat. Seek emergency medical care immediately if these symptoms occur.
Elderly individuals often have reduced renal function, which can affect drug clearance. Dose adjustments based on renal function are frequently necessary; your prescriber will assess the appropriate regimen.
Cephalexin is an antibiotic belonging to the first-generation cephalosporin class. It is available in the United Kingdom as a prescription-only medication (Rx) and is marketed in pill form, most commonly as 500 mg tablets. The drug is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Cephalexin works by interfering with bacterial cell-wall synthesis and is used to treat a variety of bacterial infections in adults.
Cephalexin targets the enzymes known as penicillin-binding proteins (PBPs) that are essential for building the peptidoglycan layer of bacterial cell walls. By binding to these PBPs, cephalexin prevents the cross-linking of peptidoglycan strands, leading to a weakened cell wall that ruptures under normal osmotic pressure. The result is bacterial death (bactericidal activity).
In the UK, cephalexin is approved for the treatment of the following infections, based on MHRA-authorized indications:
The medication is selected when the causative bacteria are known or suspected to be sensitive to first-generation cephalosporins, such as Staphylococcus aureus (non-MRSA), Streptococcus species, and certain Gram-negative bacilli.
These reactions occur in more than 1 % of patients and usually resolve without additional treatment. Maintaining adequate hydration can help mitigate diarrhoea.
This article provides educational information about cephalexin and is not a substitute for professional medical advice. Treatment decisions, including the use of cephalexin for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
